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The ability to screen and identify new ligands for cell
surface receptors has been a long-standing goal as it
might allow targeting of pharmaceutically relevant
receptors, such as integrins or G protein coupled
receptors. Here, we present a method to amplify
hits from a library of PNA-tagged peptides. To this
end, human cells, overexpressing either integrins or
the CCR6 receptor, were treated with a 10,000 mem-
ber PNA-encoded peptide library. Extraction of the
PNA tags from the surface of the cells was followed
by a PNA-tag to DNA translation and amplification
enabling decoding of the tags via microarray hybrid-
ization. This approach to ligand discovery facilitates
screening for differences in surface-receptor ligands
and/or receptor expression between different cell
types, and opens up a practical approach to PNA-
tag amplification.
INTRODUCTION
Numerous tagging strategies for combinatorial libraries have
been developed with perhaps the most commonly applied
approach at this time being DNA-encoding (Franch et al.,
2007; Wrenn et al., 2007; Clark et al., 2009; Buller et al., 2009).
The advantages of nucleic acid encoding are manifold, including
the opportunities for massively parallel and quantitative decod-
ing, either by the application of next generation sequencing or
microarray approaches, which allow not only the identification
and relative quantification of ‘‘hits’’ but also the generation of
structure-activity relationships (Brenner and Lerner, 1992; Nee-
dels et al., 1993; Nielsen et al., 1993; Ben-Dor et al., 2000;
Melkko et al., 2004; Gartner et al., 2004; Morgan et al., 2005;
Scheuermann et al., 2006).
PNA is a DNA mimic, which offers great resistance to biolog-
ical degradation while having a high binding affinity for DNA,
factors that render PNA a valuable encoding alternative to DNA
(Winssinger et al., 2001, 2002; Dı´az-Mocho´n et al., 2005; Harris
and Winssinger, 2005; Urbina et al., 2006; Debaene et al.,
2007; Pianowski and Winssinger, 2008) especially for in vivo
applications (Demidov et al., 1994; Nielsen, 2004). As such,
PNA-encoding of small molecules has allowed investigation of1284 Chemistry & Biology 18, 1284–1289, October 28, 2011 ª2011 Ecomplex biological targets for the identification of specific sub-
strates for proteases (Winssinger et al., 2001, 2002, 2004; Urbina
et al., 2006; Dı´az-Mocho´n et al., 2006) and tyrosine kinases
(Dı´az-Mocho´n et al., 2005) as well as the identification of cell
penetrating homing peptides (Svensen et al., 2011a). However,
a classic downside to PNA-encoding is that PNA cannot be
amplified by standard nucleic acid amplification techniques
(Nielsen, 2004). Thus, if a screen yields a low concentration of
PNA-tags, which are below those needed for microarray anal-
ysis, then the screen would fail unless a method could be devel-
oped for amplification of the PNA-tags.
Herein we report the screening of a 10,000 member PNA-
encoded peptide library (Library-1; Figure 1) (Pouchain et al.,
2007; Svensen et al., 2011b) with live cells and the decoding
of the attached ligands via indirect DNA amplification of the
PNA-tags with subsequent microarray analysis. Decoding was
achieved via hybridization of the isolated PNA with a 10,000
member single stranded (ss) DNA library complementary to the
10,000 members of the PNA library followed by degradation of
non-hybridized ssDNA. Asymmetric PCR amplification of the
DNA (protected by the PNA) with a fluorescent primer generated
ssDNA, which could be analyzed using DNA microarrays (Fig-
ure 1). This allowed information on the interaction between the
peptide ligands and the cell surface receptors to be extracted
on a spot-by-spot (compound-by-compound) basis.RESULTS AND DISCUSSION
Amplification of PNA Signal
Library-1 (Svensen et al., 2011b) designed to bind integrins was
based on the peptide sequence reported by Kuratomi et al.
(1999) and consisted of 10,000 nonapeptide-PNA conjugates
with four variable positions each containing 10 different amino
acids: Ac-Phe-Gln-AA4-AA3-Tyr-AA2-AA1-Ile-Lys-PNA17-fluo-
rescein with each variable amino acid encoded by a PNA-triplet
(Figure 1) (Pouchain et al., 2007). This library (10 mM, correspond-
ing to 1 nM of each library member) was incubated with the cell
lines D54 (overexpressing avb5 and avb3 integrins) (Gomez-Man-
zano et al., 1996; Fueyo et al., 1998) and HEK293T-CCR6 (over-
expressing CCR6) (Zaballos et al., 1996). Following incubation
and washing, pronase degradation of extracellular receptor
moieties as well as any bound peptide ligands allowed release
of the PNA tags (corresponding to peptides attached to the
cell surface). Due to the limited number of cells and receptors
expressed on the cell surface the amount of purified PNA waslsevier Ltd All rights reserved
Figure 1. Screening 10,000 PNA-Encoded Peptide Ligands and
PNA-Tag Amplification
(A) The general strategy for the identification of ligands for cell surface
receptors by microarray analysis of a library of PNA-encoded peptide ligands.
(B) Generic structure of Library-1. AA1, AA2, and AA4 were Ile, Val, Phe, Pro,
Arg, Glu, Lys, d-Pro, Ser or d-Val and AA3 Ile, Val, Phe, Ala, Pro, Arg, Glu, Lys,
d-ALa, Ser, or Pro. FAM is 5(6)-carboxyfluorescein amide.
(C) The strategy of indirect amplification of the PNA-tags. The PNA extracted
from cells was hybridized with a complementary ssDNA library (ssDNA-
Library-1) and unhybridized ssDNAwas degradedwith a single-strand specific
nuclease. The PNA/DNA duplexes were amplified by PCR to produce fluo-
rescently labeled ssDNA analogous to the PNAs extracted from cells. The
fluorescently labeled ssDNAwas hybridized to a complementarymicroarray to
allow decoding of the amplified ssDNA (and hence the PNA-tags and their
encoded peptides).
See also Table S1.
Figure 2. DNA Gel Electrophoresis of the Amplified PNA
(A) Proof of concept of PNA amplification. (i) oligonucleotides-2 and -3; (ii)
oligonucleotide-1; (iii) dsDNA/PNA complex; (iv) oligonucleotides-1, -2 and -3
(ssDNA/dsDNA hybrid complex).
(B) Library-1: Control showing the PCR amplified 10,000 member PNA-
Library-1 (ssDNA-Library-1-FAM); D54: FAM-labeled ssDNA decoded library
(ssDNA-D54-FAM); CCR6: FAM-labeled ssDNA decoded library (ssDNA-
HEK293T-CCR6-FAM).
See also Figure S1.
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PNA to DNA Decodingless than required for microarray analysis (see Supplemental
Information available online), and an approach was therefore
developed, which involved indirect amplification of the PNA-
tags (Figure 1).Chemistry & Biology 18, 1284–1Ten thousand complementary ssDNA oligonucleotides
(ssDNA-Library-1) (Supplemental Information) were generated
by direct amplification ‘‘off’’ a DNA microarray and this was
hybridized to the recovered PNA and to oligonucleotide-2 and
-3 (Svensen et al., 2011c) (Figure 1; Table S1). This was followed
by nuclease degradation of the ssDNA (S1 nuclease) and
purification of thedsDNA/PNAcomplexes by gel columnfiltration
(Figure 1). Because the isolated PNA-tags protected their com-
plementary DNAs from S1 nuclease degradation, only DNA
complementary to the PNA tagswas available for PCR amplifica-
tion and subsequent microarray analysis. Oligonucleotide-2 and
-3 served to protect the primer binding domains of the DNA
from nuclease degradation (Figure 1). The purified dsDNA/PNA
complexes were then amplified by asymmetric PCR using a
FAM-labeled primer (Table S1) producing FAM-labeled ssDNA
decoded libraries (ssDNA-D54-FAM, and ssDNA-HEK293T-
CCR6-FAM) (Figure 2). As a positive control the ssDNA-Library-1
was hybridizedwith the 10,000member PNA-Library-1 aswell as
oligonucleotides-2 and -3, which was followed by nuclease
degradation and asymmetric PCR amplification as described
above, generating a 10,000 member FAM-labeled ssDNA de-
coded library (ssDNA-Library-1-FAM) (Figure 2).
This approachwas initially validatedby hybridization of a single
DNA oligonucleotide (oligonucleotide-1, [ii]; [Table S1] with a
strand of PNA [TGTTTGTTTGTT] [Svensen et al., 2008]) as well
as oligonucleotides-2 and -3 ([i]; Table S1) to give a double
stranded DNA/PNA duplex (Figures 1 and 2). This hybridization
reaction was treated with a single-strand specific DNase (Fig-
ure 2, [iii]). A negative control hybridization (of oligonucleo-
tides-1, -2, and -3) and nuclease digestion were carried out in
the absence of protective PNA resulting in complete DNA degra-
dation illustrating that the DNA protected PNA can be selectively
amplified (Figures 1 and 2, [iv]).
Microarray Hybridization and Deconvolution of the Data
The DNA microarrays used contained 4 3 44,000 features
with four copies of each library member and 4000 controls on
each 44 K subarray. The FAM-labeled ssDNA decoded libraries289, October 28, 2011 ª2011 Elsevier Ltd All rights reserved 1285






Ahx, aminohexanoic acid; p, d-Pro.
Figure 3. Flow Cytometry Analysis of Peptides Binding to D54 Cells
(A) FAM versus Rho-filtered scatter plots gated for live, single cells following
incubation with (v), (vii), and (viii) using a FACS Aria cytometer with FITC and
PE-Texas-Red filters (10,000 populations, n = 3). D54 cells were detached by
scraping for minimal destruction of the extracellular receptor moieties or by
trypsin/EDTA as a control for extracellular binding of peptides.
(B) Mean FAM and Rho-filtered fluorescence of scatter plots versus incubation
with the labeled peptides. Error bars indicate ± standard deviation (SD) (n = 3).
See also Figures S2 and S3.
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PNA to DNA Decodingwere hybridized to a DNA-microarray complementary to the
17 bp PNA encoding domains. Microarray imaging and analysis
was used to extract the intensity of the FAM-label, thereby allow-
ing the relative amount of PNA extracted from the cells and
hence the peptides binding to the cells to be determined. Data
analysis allowed identification of the top 100 binding peptides
from the 10,000 member library (Supplemental Information).
Scatter plots of the relative cellular-peptide binding affinity
for the top 100 peptides versus the variable amino acids for
positions AA4 to AA1 were constructed (Figure S1). This allowed
identification of the most preferred amino acids for each of the
variable positions (i.e., the amino acids with the highest number
of high-intensity peptides): FQSIYPpIK and FQIPYIIIK for D54,
and HEK293T-CCR6 cells, respectively.
Synthesis of ‘‘Hit’’ Peptides
To verify and quantitatively compare cellular affinities of the
‘‘hit’’-peptides (Figure S1) the fluorescein-labeled peptides,
FAM-Ahx-FQSIYPpIK-NH2 [Table 1, (v); p = d-Pro and Ahx =
aminohexanoic acid] and FAM-Ahx-FQIPYIIIK-NH2 [Table 1,
(vi)] were synthesized (Dı´az-Mocho´n et al., 2005; Svensen
et al., 2008). As a positive control for integrin binding the fluores-
cein and rhodamine-labeled peptides, FAM-Ahx-RGD-NH2
[Table 1, (vii)] and Rho-Ahx-RGD-NH2 [Table 1, (viii)] were also
synthesized.
Peptide-Cell Binding Is Peptide-Specific
D54, HEK293T, and HEK293T-CCR6 cells were analyzed by flow
cytometry following incubation with the FAM-labeled peptides or
with a CCR6 antibody (anti-human CCR6). D54 cells bound the
identified integrin peptide ligand (v) as evidenced by induction
of a significant shift in the level of fluorescence compared to
that of the untreated cells (Figure 3; Figure S2). Furthermore,
this shift was similar in magnitude to that induced by the positive
control (vii; at the same concentration) showing that these
peptides have a similar affinity. Treatment with pronase/EDTA
totally removed the fluorescence signal of peptide (vii) demon-
strating that the peptide is associated with the cell surface (Fig-
ure 3; Figure S2). Incubation with (viii) and (v) at equimolar
concentrations reduced (v) binding by 55% and (viii) binding by
57%, whereas (viii) binding was reduced by 80% following the
addition of 10 equivalents of (v), illustrating that binding is integrin
mediated.
In HEK293T-CCR6 cells, the identified peptide (vi) induced a
significant shift in the level of fluorescence compared to that of
the untreated cells and this was slightly smaller than that induced
by the FAM-labeled CCR6 antibody. Again treatment with pro-
nase/EDTA reduced the fluorescence signal of the peptides1286 Chemistry & Biology 18, 1284–1289, October 28, 2011 ª2011 Edemonstrating that the peptides were associated with the cell
surface (Figure 4; Figure S2).
Peptide-Cell Binding Is Receptor-Mediated
To verify that binding of the identified ligands was mediated by
the receptor in question, a soluble inhibitor for the respective
receptor, labeled with a different fluorophore than the peptides,
was coincubated with the peptides. The D54 cells overexpress
avb5 and avb3 integrins (Gomez-Manzano et al., 1996; Fueyo
et al., 1998; Coughlan et al., 2009), which can be blocked bylsevier Ltd All rights reserved
Figure 4. Flow Cytometry Analysis of Peptides Binding to HEK293T-
CCR6 Cells
(A) FAM versus peridinin chlorophyll protein complex (PerCP)-filtered scatter
plots gated for live, single cells following incubation with (vi) or anti-human
CCR6 using FITC and PE-Texas-Red filters. Conditions as given in Figure 3.
(B) Mean FAM and PerCP-filtered fluorescence of scatter plots versus incu-
bation with (vi) and the CCR6 antibodies. Error bars indicate ± SD (n = 3).
See also Figures S2 and S3.
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PNA to DNA Decodingthe natural ligand, RGD; whereas, the CCR6 receptor can be
blocked by antihuman CCR6.
Incubation with PerCP-labeled CCR6 antibody and (vi [10 mM])
reduced binding of the peptide by 56% and the antibody by 58%
(Figure 4; Figure S2). Increase in peptide concentration by
a factor of 10 completely blocked antihuman CCR6 binding
demonstrating that (vi) binding is CCR6 mediated. As a negative
control for CCR6 binding unmodified HEK293T cells were incu-
bated with (vi) and CCR6 antibody. As expected, negligible shifts
in the levels of fluorescence were induced in HEK293T cells
compared to HEK293T-CCR6 cells and no competition betweenChemistry & Biology 18, 1284–1(vi) the CCR6 antibody was observed, which further illustrates
that (vi) binding is CCR6 mediated (Figure S2).
In order for the peptides to have biological applications it is
vital that they do not exhibit cytotoxicity. Cell viability upon treat-
ment with the ‘‘hit’’ peptides was assessed with standard MTT
(Mosmann, 1983) assays and demonstrated no cytotoxicity by
the two peptides (Figure S3).
This technique for amplification of the PNA-tags allows
screening of live cells (both adherent and suspension) and
screening of targets in scarce amounts. As screening is carried
out prior to decoding and PNA is not biologically degraded
(Demidov et al., 1994; Nielsen, 2004), the technology is appli-
cable for screening in vivo as well as in vitro.
This approach establishes a strategy for high-throughput
screening for the identification of ligands for integrins and
GPCRs offering an approach to de-orphanize GPCRs, for which
there are no known ligands. As integrins and GPCRs are among
the most heavily investigated drug targets in the pharmaceutical
industry today (Miller et al., 2000; Filmore, 2004; Insel et al., 2007)
identification of new agonist or antagonists of these receptors by
this method could help identify new drug-targets as well as
leads. The technology would also allow screening of a wide
variety of other cell surface receptors and offers a tool for inves-
tigating differences in membrane receptor expression between
different cell types including diseased cells.
This decoding strategy is amenable to the screening of larger
libraries (e.g., containing millions of compounds), either through
microarray hybridization strategies using high density arrays
(such as those from Nimblegen) or via next-generation se-
quencing. Although it has not yet been of validated with nonpep-
tidic compounds, the PNA encoding strategy is sufficiently
robust to enable tagging of either small molecules or peptides.
SIGNIFICANCE
Cellular incubation with a 10,000 member PNA encoded
peptide library followed by PNA to DNA amplification as
well as microarray and scatter plot analysis allowed con-
sensus sequences for receptor binding (v and vi) to be ex-
tracted for avb5 and avb3 integrins and CCR6 respectively.
Synthesis of these ‘‘hit’’-peptides followed by flow cytome-
try analysis verified receptor binding and demonstrated no
cytotoxicity. Competition studies with the natural ligand
for integrins, (vii) and an antibody for CCR6 demonstrated




HEK293T, HEK293T-CCR6, and D54 cells were maintained in DMEM (Supple-
mental Experimental Procedures). All cells were grown in T-75 or T-25 flasks
(Nunc) in high humidity and 5% CO2 at 37
C. Cell lines were passaged by
standard trypsinization (Supplemental Experimental Procedures).
Library Extraction from Cells
D54 and HEK293T-CCR6 cells were incubated with Library-1 (4 ml, 10 mM)
in DMEM enriched with CaCl2 (50 mM) and MgCl2 (50 mM) for 30 min at
37C. The media was removed and the cells were washed and treated with
13 pronase/EDTA in PBS for 20 min at 37C (Supplemental Experimental289, October 28, 2011 ª2011 Elsevier Ltd All rights reserved 1287
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PNA to DNA DecodingProcedures). The cells were pelleted by centrifugation, the supernatant was
recovered, and the PNA-peptide conjugates were purified by filter-centrifuga-
tion affording surface bound PNA encoded peptides extracted from D54
(4.4 pmol), and HEK293T-CCR6 (2.4 pmol).
Decoding of the PNA-Tags
The PNA extracted from cells was hybridized to the complementary 10,000
member ssDNA-Library-1 as well as oligonucleotide-2 and -3 (Table S1 and
Supplemental Experimental Procedures). Hereby, oligonucleotide-2 and -3
bound to the primer domains of all of the 10,000 ssDNA-Library-1 members
and the PNA bound to the complementary sequences of the ssDNA-Library-1.
This produced a mixture of DNA/PNA complexes: PNA/ssDNA/oligonucleo-
tide-2 and -3 (fully double stranded) and ssDNA/oligonucleotide-2 and -3
(partly double stranded) as well as excess oligonucleotide-2 and -3 (Figures
1 and 2). The single stranded domains of the ssDNA/oligonucleotide-2 and
-3 complexes and the excess oligonucleotide-2 and -3 could then be
degraded by a single strand specific DNase, whereas the double stranded
PNA/ssDNA/oligonucleotide-2 and -3 complexes were inert to nuclease
degradation (Supplemental Experimental Procedures). Thus, the PNA/
ssDNA/oligonucleotide-2 and -3 complexes comprised only the DNA strands,
which were complementary to the PNA extracted from cells, whereas all other
noncomplementary DNA strands had been degraded (Supplemental Experi-
mental Procedures).
Hereafter, the ssDNA oligonucleotides in the PNA/ssDNA/oligonucleotide-2
and -3 complexes were selectively amplified by asymmetric PCR using a
FAM-labeled primer (Table S1 and Supplemental Experimental Procedures),
which produced FAM-labeled ssDNA libraries that were complementary to
the PNA extracted from cells (ssDNA-D54-FAM and ssDNA-HEK293T-
CCR6-FAM; Figure 2). As a negative control the 10,000 PNA-tags in the
untreated PNA-Library-1 were also amplified in this manner, which produced
a FAM-labeled ssDNA library complementary to the 10,000 member PNA-
Library-1 (ssDNA-Library-1-FAM) (Figure 2; Supplemental Experimental
Procedures). FAM-labeling during PCR amplification allowed subsequent
microarray interrogation of the DNA libraries.
Microarray Hybridization
Library-1 complementary DNA microarrays (Oxford Gene Technology) were
hybridized with the purified ssDNA-FAM (Supplemental Experimental
Procedures) in 0.1% SDS in 4 3 SSPE buffer (110 ml) overnight from 65C to
27C and the arrays were washed with 0.2% SDS in 2 3 SSC for 5 min,
0.2 3 SSC for 5 min, 0.1 3 SSC for 5 min, and briefly rinsed in DNA grade
H2O and 10 mM Tris buffer at pH 8.0 and dried under N2 flow. The microarrays
were imaged and the images were analyzed using Bluefuse software
(ArrayExpress database, accession number E-MEXP-3104; Supplemental
Experimental Procedures).
Deconvolution of Microarray Data
Rawmicroarray data was obtained fromBluefuse (Supplemental Experimental
Procedures). The average fluorescence intensity was calculated over each of
the four replicates and over the noncomplementary negative control features.
The average intensities were corrected for the background and normalized for
the Library-1 hybridization (Supplemental Experimental Procedures).
Peptide Synthesis
Peptides were synthesized by solid-phase synthesis according to previously
reported procedures (Dı´az-Mocho´n et al., 2005; Svensen et al., 2008; Supple-
mentary information). The peptide-PNA conjugates were cleaved from
the solid support by treatment with 5% TIS in TFA (500 ml) for 2 3 2 hr and
the products were precipitated with cold diethyl ether (32) and collected by
centrifugation. The peptides were purified by HPLC (Supplemental Experi-
mental Procedures).
Flow Cytometry
HEK293T and HEK293T-CCR6 cells (Supplemental Experimental Procedures)
were incubated with PerCP-anti human CCR6 (10 mg/ml), FAM-anti human
CCR6 (10 mg/ml), FAM-Ahx-FQIPYIIIK-NH2 (10 mM), as well as PerCP-anti
human CCR6 (10 mg/ml) and FAM-Ahx-FQIPYIIIK-NH2 (10–100 mM) in
DMEM enriched with CaCl2 (50 mM) and MgCl2 (50 mM) for 30 min at 37
C.1288 Chemistry & Biology 18, 1284–1289, October 28, 2011 ª2011 ED54 cells were incubated with: FAM-Ahx-RGD-NH2 (10 mM), Rho-Ahx-RGD
(10 mM), (10 mM), FAM-Ahx-FQSIYPpIK-NH2 (10 mM) as well as (10 mM)
Rho-Ahx-RGD-NH2 (10 mM) and FAM-Ahx-FQSIYPpIK-NH2 (10-100 mM) in
DMEM enriched with CaCl2 (50 mM) and MgCl2 (50 mM) for 30 min at 37
C.
Hereafter, the media was removed and the cells were washed, detached by
scraping or by treatment with 13 pronase/EDTA for 15 min at 37C, sus-
pended in PBS enriched with CaCl2 (50 mM) and MgCl2 (50 mM), and analyzed
by flow cytometry (Supplemental Experimental Procedures). Compensation
was applied between the FAM/PerCP and the FAM/Rho fluorophore pairs.
Cytotoxicity Assays
D54 and HEK293T-CCR6 cells were incubated with FAM-labeled peptide
(100 mM) in appropriate growth media for 24 hr at 37C (Supplemental Exper-
imental Procedures) and the media was removed and fresh media was added
and the incubation continued for 24 hr. Cells were washed with PBS and MTT
(50 ml, 1mg/ml) in IMDMwas added and incubated for 4 hr at 37C, followed by
addition of MTT solubilizing solution (Supplemental Experimental Procedures).
Hereafter, the well-plate was shaken till complete dissolution of the formazan
crystals and the absorbance was measured at 570 nm in a microplate reader
(Supplemental Experimental Procedures). Untreated cells were considered to
be 100% viable.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.chembiol.2011.07.017.
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